Show menu

News

image
Sale of our Limoges Botanical Actives and In Vitro Diagnostics activities to Solabia 
SEQENS today announced the sale of its Botanical Actives and In Vitro Diagnostics (“IVD”) activities located in Limoges (France) to Solabia, a global player specializing in high‑value natural ingredients for personal care, life sciences and diagnostics applications.  
Read more
image
Seqens and KK India petroleum specialties PVT LTD announce new partnership for lubricant additives in India
Read more
image
Skinification: plant polysaccharides rescue damaged hair
Read more
image
Seqens partners with Pleryon to develop and manufacture an innovative GMP Polymer to treat osteoarthritis
Read more
image
Seqens confirms the acquisition of CELLforCURE
Read more
image
New investments in China
Read more
image
Seqens group at DCAT Week 2023
Read more
image
Seqens Group Opens Flagship Pharmaceutical R&D Center in Boston
Read more
image
SEQENS Makes Multi-Million-Dollar Investment in U.S. R&D Laboratory
Read more
image
Meeting with Virginie Tarlet for the International Women’s Day
Read more
image
Meeting with Yael Gofni for the International Women’s Day
Read more
image
Update on isopropanol plant expansion
Read more
image
SK Capital becomes the new majority shareholder of Seqens – Q&A
Read more
1 2 3 4 5 6